Electrophoresis Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Electrophoresis, Agarose & Polyacrylamide Gel, Capillary Electrophoresis, Isoelectric Focusing, Isotachophoresis, CZE, CGE, MEKC, Reagents and Informatics), By Application (Diagnostic, Research and Quality Control & Process Validation), By End User (Academic Institutions, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies and Research Organizations) and Region Forecast 2020-2031

Electrophoresis Market size was valued at US$ 3.3 billion in 2024 and is expected to reach US$ 4.8 billion by 2031, growing at a significant CAGR of 5.7% from 2025-2031. Electrophoresis is a laboratory technique used to separate molecules, typically proteins, nucleic acids (like DNA or RNA), or other charged particles, based on their size, charge, and mobility in an electric field. It is a fundamental method in biochemistry, molecular biology, and genetics for various applications, including DNA sequencing, protein analysis, and the purification of biomolecules. The rising application of electrophoresis in clinical diagnostics has become a significant driver for the growth of the market revenues. Electrophoresis plays a crucial role in clinical laboratories for the analysis of biomolecules such as proteins, nucleic acids, and serum components. It enables the separation and quantification of these molecules, facilitating the diagnosis and monitoring of various medical conditions, including genetic disorders, hemoglobinopathies, autoimmune diseases, and certain cancers. The accuracy and reliability of electrophoresis in identifying biomarkers and disease-associated patterns make it an indispensable tool for clinicians and pathologists.

Moreover, pharmaceutical and biopharmaceutical development significantly drive the demand for electrophoresis technologies and solutions. Researchers and scientists in drug discovery, biopharmaceutical development, and quality control rely on electrophoresis to assess the purity, integrity, and structural properties of therapeutic proteins and nucleic acid-based drugs. It aids in identifying and quantifying impurities, ensuring product quality, and meeting regulatory requirements. As the pharmaceutical and biopharmaceutical sectors continue to expand, driven by research into innovative therapies and biologics, the demand for precise and high-throughput electrophoresis methods remains strong, contributing significantly to the growth of the market. However, factors such as pricing pressure faced by prominent players, the presence of alternative technologies, and time-consuming operations & limited sample analysis are hampering the market growth. Meanwhile, increasing investments in research and development of genomic, proteomic, and electrophoresis techniques by healthcare organizations around the world are expected to proliferate the growth of the target market. The market is further experiencing growth owing to frequent acquisitions and launches by the market players. For Instance, in September 2020, miniPCR bio launched an integrated DNA analysis system, the GELATO electrophoresis system, for fast DNA analysis.

Key Developments       

• In September 2020, Promega launched the Spectrum Compact CE System, a benchtop capillary electrophoresis (CE) instrument, in collaboration with Hitachi High-Tech.
• In September 2021 Sciex launched a new capillary electrophoresis system, BioPhase 8800, for enhanced biologic characterization in the development of biopharmaceutical therapies.